Higgins Jack
Chief Scientific Officer
Higgins Jack has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Higgins Jack is listed as Chief Scientific Officer at Immunome Inc. Inside the rolling window, Higgins Jack reported no open-market purchases and 2 open-market sales totaling $538K in IMNM. The largest disclosed transaction in the window is a sale of 13,200 IMNM shares on Sep 11, 2026, worth $334K.
Companies traded
Other insiders at IMNM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$538K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Higgins Jack made?
Higgins Jack has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Higgins Jack trade?
Higgins Jack has filed SEC Form 4 disclosures for 1 company, including IMNM.
When was Higgins Jack's most recent SEC Form 4 filing?
Higgins Jack's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Higgins Jack's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Higgins Jack is listed as Chief Scientific Officer.
What is Higgins Jack's total buy and sell value in the current window?
Inside the rolling retention window, Higgins Jack bought $0 and sold $538K based on SEC Form 4 filings.
What was Higgins Jack's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,200 IMNM shares on 2026-09-11, worth $334K, per SEC Form 4 filings.